The "new kid on the block:" Intraductal papillary mucinous neoplasms of the pancreas: Current concepts and controversies

Surgery

Volumn 133, Issue 5, 2003, Pages 459-463

  Adsay, N Volkan ^a  

^a HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN 2; PROTEIN P16; PROTEIN P53;

CANCER CYTODIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CARCINOMA IN SITU; CELL STRUCTURE; CLINICAL FEATURE; CLINICAL PRACTICE; DIFFERENTIAL DIAGNOSIS; DYSPLASIA; GENE MUTATION; GENETIC CODE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INVASIVE CARCINOMA; NOMENCLATURE; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS DUCT; PANCREATIC INTRAEPITHELIAL NEOPLASM; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0038779536     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2003.127     Document Type: Review

References (13)

1. Sarr MG, Murr M, Smyrk TC, et al. Primary cystic neoplasms of the pancreas: neoplastic disorders of emerging importance: current state of art and unanswered questions. J Gastrointest Surg 2003. In press.
2. Adsay V, Conlon K, Zee SY, Brennan MF, Klimstra DS. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of in-situ and invasive carcinomas associated with 28 cases. Cancer 2002;94:62-77.
3. Kloppel G. Clinicopathologic view of intraductal papillary-mucinous tumor of the pancreas. Hepatogastroenterology 1998;45:1981-5.
4. Kloppel G, Luttges J. WHO-classification 2000: exocrine pancreatic tumors. Verh Dtsch Ges Pathol 2001;85:219-28.
5. Morohoshi T, Kanda M, Asanuma K, Kloppel G. Intraductal papillary neoplasms of the pancreas. A clinicopathologic study of six patients. Cancer 1989;64:1329-35.
6. Yamaguchi K, Tanaka M. Mucin-hypersecreting tumor of the pancreas with mucin extrusion through an enlarged papilla. Am J Gastroenterol 1991;86:835-9.
7. Yanagisawa A, Ohashi K, Hori M, et al. Ductectatic-type mucinous cystadenoma and cystadenocarcinoma of the human pancreas: a novel clinicopathological entity. Jpn J Cancer Res 1993;84:474-9.
8. Warshaw AL. Mucinous cystic tumors and mucinous ductal ectasia of the pancreas. Gastrointest Endosc 1991;37:199-201.
9. Adsay NV, Adair CF, Heffess CS, Klimstra DS. Intraductal oncocytic papillary neoplasms of the pancreas. Am J Surg Pathol 1996;20:980-94.
10. Sarr MG, Carpenter HA, Prabhakar LP, et al. Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg 2000;231:205-12.
11. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001;25:579-86.
12. Adsay NV, Merati K, Andea A, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential MUC1 and MUC2 expression supports the existence of two separate pathways of carcinogenesis. Modern Pathol 2002;15:1087-95.
13. Adsay NV, Pierson C, Sarkar F, et al. Colloid (mucinous noncystic) carcinoma of the pancreas. Am J Surg Pathol 2001;25:26-42.